Pharmacy-Based Administration of Long-Acting Injectables: A Sharp Idea

Pharmacy-Based Administration of Long-Acting Injectables: A Sharp Idea

Explore a cutting edge clinical service opportunity with this collection of courses specifically designed to equip pharmacists with the knowledge and skills necessary for the effective management and administration of long-acting injectable medications (LAIs). Course content explores diverse drug profiles, advanced administration techniques, and the strategic implementation of LAI-related services to support the needs of your patients and communities.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
Module 1
1. Describe the signs, symptoms, and diagnostic criteria for schizophrenia and bipolar disorder
2. List the benefits and challenges associated with the use of long-acting injectable (LAI) antipsychotics
3. Compare the FDA-approved LAI antipsychotics, including preparation and administration
4. Discuss the role of the pharmacist in the administration of LAI antipsychotics in the pharmacy setting
5. Formulate a strategy to transition a case-based patient from an oral antipsychotic to a LAI antipsychotic

Module 2
1. Review the various types of injections that may be delivered in pharmacy practice
2. Identify techniques and recommended practices for delivering injectable medications
3. Assess the appropriate injection method based on patient factors, medication characteristics, and safety considerations

Module 3
1. Discuss the opportunities and challenges of developing a LAI service
2. Describe the key components and procedures necessary for implementing a LAI administration service
3. Develop a policy, procedure, and plan for providing LAI administration services
4. Recognize options to expand LAI administration through community partnerships

Module 4
1. Identify the considerations for administering long-acting injectables (LAIs)
2. Describe common FDA-approved non-antipsychotic LAIs administered at the pharmacy
3. Discuss monitoring and follow-up plan recommendations for each injection
4. Develop a treatment plan to transition a case-based patient from an oral medication to an LAI non- antipsychotic

Katelynn Mayberry, PharmD
Clinical Assistant Professor of Pharmacy Practice
Mercer University College of Pharmacy

Elizabeth Skoy, PharmD, FAPhA
Professor
North Dakota State University

Lindsay McCoy, PharmD, BCPP
Pharmacy Manager
Village Drug Shop at Advantage

Katelynn Mayberry, Elizabeth Skoy, and Lindsay McCoy have no relevant financial relationships with ineligible companies to disclose.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: November 12, 2024
Planned Expiration Date: November 12, 2027

Copyright 2024, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

Universal Activity Number (UAN): 0107-0000-24-312-H01-P
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information

Duration

4h 0m

Topic Designator

Disease State/Drug Therapy

ACPE

Yes

ACPE Topic

01 Drug Therapy

Role

Pharmacist

Media-Type

On-Demand

Release Date

8/1/24

CEUs

0.4

ACPE Number

0107-0000-24-312-H01-P

This course is in our subscription.

Stay confident and competent.

Join over 100,000 Pharmacists & Technicians in our Pharmacy Community!

Experience the difference with CEimpact Education

Let's have a chat

0